Recognition of Special form of Amphetamine Acquaintance in Iran and Presentation of 4 cases with Neurovascular Complication

Document Type : Case report


1 Associated Professor of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

2 Assistant Professor of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

3 Pharmacologist, Mashhad University of Medical Sciences, Mashhad, Iran

4 Neurologist, Mashhad University of Medical Sciences, Mashhad, Iran


Ecstasy and crystal are recently new most widely abused illegal drugs in Iran. Ecstasy/MDMA abuse may cause acute complications that have fatal consequences.
Cases report
Pt 1: A 26 year old who referred to emergency room due to acute paraplegia and finally died with cardiac arrest.
Pt 2: A 45 year old woman who came with seizure disorder and unconsciousness. Finally she died due to cardiac arrest.
Pt 3: A 32 year old man was admitted due to acute flaccid paraplegia. He had diffused skin rash due to vasculitis. The patient died despite of supportive cares.
Pt 4: A 23 year old man who referred to neurological ward because of generalized tonic-clonic seizures following Crystal and Ecstasy abuse. The patient was discharged after 4 days with good general conditions.
Unfortunately recently, the rate of Ecstasy and Crystal drugs abusers in Iran have increased. This paper notify about the neurological side effects of these drugs.


1- Bousser MG, Barnett HJM. Cerebral venous thrombosis. In: Barnett HJM, Mohr JP, Stein BM. Stroke. 3rd
ed.Philadelphia: Churghill-Livingstone; 1998.p.623-642.
2- Biller J, Love B. Ischemic cerebrovascular Disease. In: Bradley WG, Daroff RB, Fenichel GM. Neurology in clinical
practice. 4thed. Philadelphia: Butterworth-Heinemann; 2004.p.1243-1246.
3- Ropper AH, Brown RH. Adams and Victor’s Principle of Neurology. 8thed. New York: McGraw-Hill; 2005.p.734-738.
4- Fishman RA. Cerebral veins and sinuses. In: Rowland LP. Merriit Neurology. 11th ed. Philadelphia: Lippincott
WillIams & Wilkins; 2005.p.338-341.
5- Dentali F, Gianni M, Growth MA. Natural history of cerebral vein thrombosis. Blood 2006; 108:1129-1134.
6- Black C, Kaye JA. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive. Br J
clin Phamacol 2002; 53: 637-640.
7- Raes Mc, Tranhoschulman S. Effect of patient sex on risk of recurrent venous thromboembolism. Ameta – analy.
Lancet 2006; 368: 371-378.
8- Koster T, Small R. Oral contraceptive and venous thromboembolies. J Intermed 1995; 238:31-37.
9- Kapessidou Y, Vokaer M, Lavreys M, Bier JC, Boogaerts JG. Cases report. Cerebral vein thrombosis after
subarachnoid analgesics for labour. Can J Anaesth 2006; 53:1015-1019.
10- Wiste E, Sokinska W. Cerebral venous sinus thrombosis. Neurology 2006; 67: 814-819.